WebinarWound

From LCD Rumors to (Delayed) Reality: Navigating the Postponed 2025 LCD for Skin Substitutes

The implementation date of the highly anticipated 2025 Local Coverage Determinations (LCDs) for skin substitutes has been postponed until 4/13/2025, leaving providers and patients in a holding pattern. What does this delay really mean for your practice, and how do Medicare Administrative Contractors (MACs) historically approach such transitions?

Join us for an expert panel discussion featuring three distinguished speakers who will provide comprehensive insights into both current requirements and future changes.

 

Featured Speakers:

  • Dr. Harry Feliciano, M.D., MPH, Former Senior Medical Director at Palmetto GBA and lead Contractor Medical Director for home health and hospice coverage policy
  • Dr. Jeffrey Lehrman, DPM, nationally recognized certified professional coder and certified professional medical auditor
  • Dr. Gunnar Johannsson, M.D., SVP of Health Policy & Medical Director at Kerecis

 

New Focus Points

MAC Perspectives on Coverage Transitions

    • Historical approaches to coverage changes and LCD implementations
    • Understanding how MACs interpret and apply “Reasonable and Necessary” criteria during transition periods
    • Key insights from Dr. Feliciano’s experience in MAC coverage policy development

 

What to Expect From Medicare and the MACs During the Delay

    • Will policies remain unchanged?
    • How current MAC medical policies influence coverage decisions
    • Practical implications for providers during the transition period

 

Advocating For or Against the LCD

    • Understanding the MAC review process and effective advocacy strategies
    • Why your input matters during the delay—and how providers, industry, and patients can make their voices heard

 

Preparing Your Practice Now

    • Staying compliant under current rules
    • Updating documentation protocols
    • Planning for eventual LCD implementation


Continuing Core Topics

Coding Best Practices

    • Proper use of modifiers, wastage documentation, and navigating CPT and HCPCS codes—especially in the Wound Care Center setting

 

Product-Specific Guidance

    • Which Kerecis product can be applied over bone and tendon?
    • How do you code for Kerecis Micro products?
    • What if a patient has already received 8 skin substitutes from another provider?

 

Avoiding Common Pitfalls

    • Practical strategies for compliance, minimizing denials, and maximizing patient access to quality care

 


Extended Q&A Session

  • Your chance to ask our expert panel about MAC coverage policies, coding practices, and clinical applications
  • Special focus on understanding historical MAC approaches to coverage transitions and implementation periods

 

Don’t miss this essential update on the current and future state of skin substitute coverage. Whether you’re looking for clarity on immediate coding practices or guidance on how to shape the LCD’s final form, this webinar provides the insights you need to stay ahead.

Date

February 12, 2025
5:00 pm
EST

Speakers & host

  • Dr. Harry FelicianoM.D., MPHSpeaker
  • Dr. Jeffrey LehrmanDPM, FASPS, MAPWCA, CPC, CPMA Speaker
  • Dr. Gunnar JohannssonM.D., SVP of Health Policy & Medical Director at KerecisHost

Watch past webinars

    Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy.
    Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.